(Q44602400)

4 December 2017

title

Clinical pharmacology of flavopiridol following a 72-hour continuous infusion (English)

1 reference

4 December 2017

Clinical Pharmacology of Flavopiridol following a 72-Hour Continuous Infusion (English)

1 reference

16 March 2024

1 reference

clinical pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

author name string

Michelle A. Rudek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

Kenneth S. Bauer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

Richard M. Lush

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

Sherman F. Stinson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

Adrian M. Senderowicz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

Donna J. Headlee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

Susan G. Arbuck

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

Michael C. Cox

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

Anthony J. Murgo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

Edward A. Sausville

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

William D. Figg

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14519054

16 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

http://journals.sagepub.com/doi/pdf/10.1345/aph.1C404

1 reference

http://journals.sagepub.com/doi/full-xml/10.1345/aph.1C404

16 March 2024

1 reference

Annals of Pharmacotherapy

16 March 2024

published in

1 reference

4 December 2017

volume

37

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1369-1374

1 reference

Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity

4 December 2017

cites work

1 reference

Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275.

21 January 2018

1 reference

Mechanisms of action of flavopiridol

21 January 2018

1 reference

Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.

21 January 2018

1 reference

Determination of flavopiridol (L86 8275; NSC 649890) in human plasma by reversed-phase liquid chromatography with electrochemical detection.

21 January 2018

1 reference

Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms

21 January 2018

1 reference

Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells--potential role in carcinogen bioinactivation

21 January 2018

1 reference

Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients.

21 January 2018

1 reference

Clinical pharmacokinetics of irinotecan and its metabolites in relation with diarrhea

21 January 2018

1 reference

Role of cholecystokinin in the regulation of gastrointestinal motility

21 January 2018

9

1 reference

Drug Metabolism and Disposition

16 March 2024

11

29

407

Hagenauer B

2001

1 reference

Saturable elimination and saturable protein binding account for flavone acetic acid pharmacokinetics

16 March 2024

12

1 reference

Drug Metabolism and Disposition

16 March 2024

17

28

1077

Walle T

2000

1 reference

Drug interactions of lipid-altering drugs

16 March 2024

18

1 reference

16 March 2024

Identifiers

DOI

10.1345/APH.1C404

1 reference

4 December 2017

1 reference